These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 978210)

  • 1. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis.
    Conradi S; Ronnevi LO; Vesterberg O
    J Neurol Sci; 1976 Oct; 29(2-4):259-65. PubMed ID: 978210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead in cerebrospinal fluid and its relationship to plasma lead in humans.
    Cavalleri A; Minoia C; Ceroni M; Poloni M
    J Appl Toxicol; 1984 Apr; 4(2):63-5. PubMed ID: 6736552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis.
    Leonardi A; Abbruzzese G; Arata L; Cocito L; Vische M
    J Neurol; 1984; 231(2):75-8. PubMed ID: 6737012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid.
    Conradi S; Ronnevi LO; Nise G; Vesterberg O
    J Neurol Sci; 1980 Dec; 48(3):413-8. PubMed ID: 7441289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
    Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
    Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyotrophic lateral sclerosis with important non-specific changes in the cerebrospinal fluid in a patient with diabetes of long standing].
    LECHELLE P; THEVENARD A; DELAPORTE J
    Bull Mem Soc Med Hop Paris; 1952 Jul 4-11; 68(24-25):941-3. PubMed ID: 12988037
    [No Abstract]   [Full Text] [Related]  

  • 7. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study.
    Vinceti M; Filippini T; Mandrioli J; Violi F; Bargellini A; Weuve J; Fini N; Grill P; Michalke B
    J Trace Elem Med Biol; 2017 Sep; 43():121-125. PubMed ID: 28089071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser nephelometric evaluation of albumin, IgG and alpha 2-macroglobulin: applications to the study of alterations of the blood-brain barrier.
    Meucci G; Rossi G; Bettini R; Montanaro D; Gironelli L; Voci L; Bianchi F
    J Neurol Sci; 1993 Aug; 118(1):73-8. PubMed ID: 7693877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcitonin level in cerebrospinal fluid of patients with amyotrophic lateral sclerosis].
    Klimek A; Stepień H; Szulc-Kuberska J; Pisarek H
    Pol Tyg Lek; 1992 Apr 6-13; 47(14-15):310-1. PubMed ID: 1437739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CSF findings in patients with ALS].
    Takase S
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1257-61. PubMed ID: 6085569
    [No Abstract]   [Full Text] [Related]  

  • 11. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia.
    Mishra PS; Vijayalakshmi K; Nalini A; Sathyaprabha TN; Kramer BW; Alladi PA; Raju TR
    J Neuroinflammation; 2017 Dec; 14(1):251. PubMed ID: 29246232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis.
    Parry GJ; Rodrigues CM; Aranha MM; Hilbert SJ; Davey C; Kelkar P; Low WC; Steer CJ
    Clin Neuropharmacol; 2010; 33(1):17-21. PubMed ID: 19935406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Benninger F; Glat MJ; Offen D; Steiner I
    J Clin Neurosci; 2016 Apr; 26():75-8. PubMed ID: 26602604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased spinal cord lead content in amyotrophic lateral sclerosis--possibly a secondary phenomenon.
    Mandybur TI; Cooper GP
    Med Hypotheses; 1979 Dec; 5(12):1313-5. PubMed ID: 537545
    [No Abstract]   [Full Text] [Related]  

  • 17. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis.
    Roos PM; Lierhagen S; Flaten TP; Syversen T; Vesterberg O; Nordberg M
    Exp Biol Med (Maywood); 2012 Jul; 237(7):803-10. PubMed ID: 22859739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis.
    Tohgi H; Abe T; Yamazaki K; Murata T; Ishizaki E; Isobe C
    Ann Neurol; 1999 Jul; 46(1):129-31. PubMed ID: 10401792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis.
    Schreiber S; Debska-Vielhaber G; Abdulla S; Machts J; Schreiber F; Kropf S; KÖrtvelyessy P; KÖrner S; Kollewe K; Petri S; Dengler R; Kunz WS; Nestor PJ; Vielhaber S
    Muscle Nerve; 2018 Feb; 57(2):273-278. PubMed ID: 28472860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.